NPSG.07.03.01 Implement evidence-based practices to prevent health care–associated infections due to multidrug-resistant organisms. This requirement applies to epidemiologically important organisms such as methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (CDI), vancomycin-resistant enterococci (VRE), carbapenem-resistant enterobacteriaceae (CRE), and other multidrug-resistant gram-negative bacteria.

EP5 Measurement of multidrug-resistant organism prevention processes

Navigation

X

National Patient Safety Goals (NPSG) Standards

Element of Performance

Measure and monitor multidrug-resistant organism prevention processes and outcomes, including the following:

Multidrug-resistant organism infection rates using evidence-based metrics
Compliance with evidence-based guidelines or best practices
Evaluation of the education program provided to staff and licensed independent practitioners

Identified Risk

Resources

Access Options

If you would like to learn more about purchasing a facility subscription to this content, please click the button below.

Learn More

EP5 Measurement of multidrug-resistant organism prevention processes

National Patient Safety Goals (NPSG) Standards

Element of Performance

Resources

Access to this content requires a facility subscription to both eGuidelines+ and the AORN Accreditation Assistant for The Joint Commission.

Access Options